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What is already known about the topic? 1 
x Globally, as demand for palliative care is increasing amongst those with life-limiting illnesses, 2 
there has been a rapid growth in specialist and generalist palliative care service provision with a 3 
range of different of models of palliative care service provision being developed and 4 
implemented internationally. 5 
x The published evidence has been synthesised in a number of reviews which have attempted to 6 
identify the effectiveness and cost effectiveness of different models of palliative care. 7 
x There is no comprehensive overview of the current evidence base to support decision-making 8 
based on the advantages and disadvantages of different models of palliative care or to identify 9 
any gaps in the evidence base where more primary research is needed. 10 
What this paper adds? 11 
x The outcomes measured vary considerably, making meta-analysis impossible. None-the-less, 12 
the available evidence indicates that irrespective of setting or patient characteristics, models of 13 
palliative care appear to show benefits for patients and their carers, with no evidence for 14 
negative effects. Some models of palliative care may reduce total healthcare costs. 15 
Heterogeneity, methodological limitations, poor reporting of models and a lack of consensus 16 
about outcome measures i.e. what constitutes "benefit to patients" makes it impossible to 17 
identify the key components that may enable replication and prediction of which models of 18 
provision are most appropriate for specific contexts or for specific patient groups. 19 
 20 
 21 
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x In addition to addressing the problems associated with heterogeneity and poor reporting 1 
within studies and reviews themselves, this comprehensive and critical review identifies 2 
significant gaps in the evidence base and the urgent need to identify models of palliative care 3 
by name, define and describe their components in detail in order to differentiate between 4 
them in both practice and research.  Consensus is required about important outcome 5 
measures in palliative care and appropriate, consistent, outcomes should be selected to 6 
demonstrate the PRGHO¶V mechanisms of action (i.e. how it works).  7 
 8 
Implications for practice, theory or policy? 9 
x Much has been written and summarised in systematic reviews about models of palliative care 10 
in a range of practice settings. However, closer examination of the evidence base highlights a 11 
number of areas that warrant further attention for this to be useful to policy makers and 12 
clinicians. Much more detailed and systematic reporting of the models in both primary research 13 
studies and systematic reviews, ideally using existing checklists such as TIDiER, is essential in 14 
order to understand the key components of successful models which could be replicated.   15 
x Further primary studies are required that assess models of palliative care as complex 16 
interventions and enable decision makers to determine which models are likely to be most 17 
effective in different settings and for different patient groups. 18 
Abstract 19 
Background: A wide range of organisational models of palliative care exist. However, decision makers 20 
need more information about which models are likely to be most effective in different settings and for 21 
different patient groups. 22 
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Aims: To identify the existing range of models of palliative care that have been evaluated, what is 1 
already known and what further information is essential if the most effective and cost-effective models 2 
are to be identified and replicated more widely. 3 
Design: A review of systematic and narrative reviews according to the Preferred Reporting Items for 4 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Study quality was assessed using the 5 
AMSTAR tool. 6 
Data sources: MEDLINE, EMBASE, PsycINFO, CINAHL, Cochrane Library, Web of Science and ASSIA were 7 
searched for reviews about models of service provision from 2000- 2014 and supplemented with Google 8 
searches of the grey literature. 9 
Results: Much of the evidence relates to home based palliative care, although some models are 10 
delivered across care settings.  Reviews report several potential advantages and few disadvantages of 11 
models of palliative care delivery. However, under-reporting of the components of intervention and 12 
comparator models are major barriers to the evaluation and implementation of models of palliative 13 
care.   14 
Conclusions: Irrespective of setting or patient characteristics, models of palliative care appear to show 15 
benefits and some models of palliative care may reduce total healthcare costs. However, much more 16 
detailed and systematic reporting of components and agreement about outcome measures is essential 17 
in order to understand the key components and successfully replicate effective organisational models. 18 
 19 
Keywords:  palliative care, models organizational, systematic review, meta-review20 
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 1 
Introduction 2 
 3 
The potential value of palliative care to improve the management of complex care needs and relieve 4 
suffering, is increasingly recognised internationally
1
. Demographic changes mean populations are living 5 
longer with more chronic and complex health needs. Hence, globally, the demand for palliative care is 6 
increasing and there has been a rapid growth in palliative care service provision
2
. Models of palliative 7 
care service provision are complex interventions
3
 developing in various ways internationally
4
 to reflect 8 
different cultures, religious beliefs, legal frameworks and resource-settings
5
. Centeno et Ăů ?Ɛ(2013) Atlas 9 
of Palliative Care
4
 classifies palliative care in Europe based on the place of provision (acute hospital; care 10 
in medium and long term places other than general hospitals and at home) and the level of intervention 11 
( ‘basic ? ? ‘ƐƉĞĐŝĂůŝƐĞĚ ? or  ‘ŽƚŚĞƌ specialised ? care). The Atlas4 a**lso provides forty-three detailed, country 12 
specific reports
4
. Internationally, generalist or specialist models of palliative care are recognised, 13 
categorised by the training and experience of the health care practitioners providing care. A key 14 
influence on palliative care provision in each country is the way that palliative and health care is 15 
funded in different systems. In 2014, the World Health Assembly (WHA) adopted a Resolution6 16 
calling upon national governments to improve access to palliative care as a core component of 17 
health systems.   18 
Given the ongoing rapid expansion of palliative care services world-wide and governmental 19 
commitments to the WHA (World Health Assembly) Resolution for further expansion, policy makers and 20 
service commissioners urgently require evidence to underpin decision-making. 21 
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*Some work attempting to identify the effectiveness and cost effectiveness of models of palliative care 1 
has been completed at review level
7
. However, in addition to evidence about the effectiveness and cost-2 
effectiveness of the various organisational models of palliative care, policy makers need review level 3 
evidence about the wider advantages (i.e. benefits to patients, carers, professionals and / or the 4 
healthcare system) and disadvantages (i.e. drawbacks to patients, carers and the healthcare system) of 5 
different models of palliative care. Furthermore, identifying which components of palliative care models 6 
are most appropriate for different patient groups and under what circumstances may provide insight 7 
into causal pathways and mechanisms of action (i.e. how each model works). This review of review level 8 
evidence builds on the existing body of evidence to assist decision making about services and the future 9 
the development and evaluation of these models as complex interventions
8
.Complex interventions are 10 
characterised by the number of interacting components they have; the number of groups or 11 
organisational levels targeted by the intervention; the number and degree of difficulty of 12 
behaviours required by those delivering or receiving the intervention; the number and variability 13 
of outcomes and the degree of flexibility or tailoring of the intervention to meet individual needs8. 14 
As the aim of palliative care LVWRPHHWSDWLHQW¶VLQGLYLGXDODQGKROLVWLFQHHds, models of care will 15 
be developed and tailored to the individual RUIDPLO\¶VQHHGV in a variety of ways. Hence, a clear 16 
statement about the underlying theory of the causal mechanisms (i.e. how the model works, for 17 
whom and under what circumstances) would assist the evaluation of models of palliative care. 18 
Indeed, understanding the key components of models of palliative care is fundamental to their 19 
evaluation. Research Aim  20 
The overall aim of this systematic review of reviews is to critically evaluate and synthesise the existing 21 
evidence base for different types of models of palliative care in different settings and identify the key 22 
gaps in the evidence base that still need to be addressed. 23 
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Methods  1 
We conducted a systematic review of systematic and narrative reviews of models of palliative care for 2 
any adult patient group with life-limiting illnesses.  Davidson et al (2006)
9
 describe models of care as an 3 
overarching design for health care service provision which consists of defined core elements. We define 4 
ƚŚĞƚĞƌŵ “ŵŽĚĞů ?ŽĨƉĂůůŝĂƚŝǀĞĐĂƌĞƐĞƌǀŝĐĞƉƌŽǀŝƐŝŽŶas shown in Box 1, providing explicit details about 5 
the  ‘core elements ? for clarity. Our definition purposefully excludes process models, such as the 6 
Liverpool Care Pathway (LCP) or Integrated Care Pathways (ICP), which focus on describing the detailed 7 
processes of care provision rather than their structural organisation. The focus on structural models is 8 
entirely appropriate given the desire to inform service commissioning. 9 
 10 
Box 1: Definition of  “ŵŽĚĞů ?ŽĨƉĂůůŝĂƚŝǀĞĐĂƌĞƐĞƌǀŝĐĞƉƌŽǀŝƐŝŽŶ 11 
 12 
 13 
 14 
Search strategy 15 
Our search strategy aimed to identify review-level evidence about different structural models of 16 
palliative care.  Excluding process models enabled a focus on the resources required to deliver service 17 
models rather than processes that assist care delivery.  18 
&ŽƌƚŚŝƐƌĞǀŝĞǁ ?ƚŚĞƚĞƌŵ ‘ŵŽĚĞů ?ŽĨƉĂůůŝĂƚŝǀĞĐĂƌĞ was defined as any structured 
care model involving multiple components including  ‘ǁŚŽ delivers (e.g. 
professionals, paid carers) the intervention (specialist or generalist palliative 
care), where (setting ʹ e.g. hospital), to whom (care recipients), when (i.e. timing 
and duration), how (e.g. face to face) and for what purpose (i.e. expected 
outcomes)? ? 
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We searched seven databases (MEDLINE via OVID SP, EMBASE via OVID SP, PsycINFO via OVID SP, 1 
CINAHL via EBSCO, Cochrane Library via Wiley Interscience (Cochrane Databases of Systematic Reviews 2 
and Database of Abstracts of Reviews of Effects) for reviews published in English between 2000 and 3 
2014 (Box 2). The search included palliative care terms with a validated systematic review filter
10
  4 
tomaximise sensitivity whilst reducing the number of records retrieved. Searches were conducted in 5 
April/May 2014 and updated in October 2014.  6 
Reference lists of included reviews were scrutinised to identify additional reviews that potentially met 7 
the inclusion criteria. We also undertook Google searches using key search terms  ? ‘ƐǇƐƚĞŵĂƚŝĐƌĞǀŝĞǁ ? ? ?8 
 ‘ƉĂůůŝĂƚŝǀĞĐĂƌĞ ? ? ‘ƐƉĞĐŝĂůŝƐƚƉĂůůŝĂƚŝǀĞĐĂƌĞ ?ĂŶĚ ‘ĂĚƵůƚƐ ? ?ƚŽexamine ten relevant  websites (Marie Curie, 9 
^ƵĞZǇĚĞƌ ?^ƚŚƌŝƐƚŽƉŚĞƌ ?Ɛ,ŽƐƉŝĐĞ ?<ŝŶŐ ?Ɛ&ƵŶĚ ?,ĞůƉƚŚ ,ŽƐƉŝĐĞ ?The National Institute for Health and 10 
Care Excellence (NICE),  The World Health Organisation (WHO), The European Association for Palliative 11 
Care (EAPC), The National Council for Palliative Care (NCPC) and Hospice UK)  for review level evidence 12 
on palliative care models.  13 
 14 
Study selection  15 
Identified citations were uploaded to a Reference Manager database and duplicate references were 16 
removed. Two reviewers independently screened all titles and abstracts (where available) to identify 17 
reviews that met the inclusion criteria (Table 1).  The full text of potentially relevant titles was 18 
independently assessed by two reviewers and, where there was disagreement, a third reviewer was 19 
consulted to determine inclusion. 20 
Assessment of quality of included studies  21 
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 1 
Following study selection, two reviewers independently assessed the methodological quality of included 2 
studies using the AMSTAR (A MeaSurement Tool to Assess Reviews) tool
11
 which was specifically 3 
designed to assess the quality of systematic reviews. Scores were totalled, allowing the review to be 4 
classified as low quality (3 or lower), medium quality (4 to 7) or high quality (8 to 11).  Reviews were 5 
included regardless of their quality. (Table 3).  6 
 7 
Data extraction 8 
Two reviewers independently extracted data from each included review using predefined and piloted 9 
data extraction forms specifically designed for the review.  Data were extracted about the key 10 
characteristics of the reviews including information about the advantages and disadvantages of models 11 
and used to inform Table 2, which was subsequently circulated to all reviewers for confirmation. No 12 
additional quality checks were made. 13 
Synthesis 14 
As the evidence base mainly consists of narrative reviews of studies with diverse methodologies, we 15 
undertook a narrative data synthesis following methods outlined by Popay et al (2006)
12
. The aim was to 16 
undertake a preliminary synthesis, with the intention of explaining which models were effective for 17 
which patient groups in which particular settings. We envisaged being able to identify causal pathways 18 
and mechanisms of action (i.e. how each model works). We also wanted to explore relationships within 19 
and between studies before determining the robustness of the synthesis. The evidence reported in each 20 
review was tabulated to provide a descriptive summary of the main characteristics and outcomes of 21 
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each included review (Table 2).  Where reported, we also extracted the definition and a description of 1 
the interventions reported as well as their components as described within each review.  The lack of 2 
detail included in the reviews limited synthesis as it was not possible to identify theory underpinning 3 
how and why the intervention works or for whom, although reviews did report on the advantages and 4 
disadvantages associated with models.  5 
Results 6 
Search results 7 
All results are presented in compliance with PRISMA guidelines
13
 (Figure 1). A total of thirteen reviews 8 
were identified from the electronic searches. A further four reviews were identified from searching the 9 
reference lists of included publications. One further publication
7
, was identified by a scoping exercise 10 
which informed the funding bid.   This review
7
 is a Health Services Assessment Collaboration publication 11 
from New Zealand and was therefore not found within the search strategy.  Eighteen reviews 
7,14-30
 met 12 
the inclusion criteria. AMSTAR quality scores ranged from 2-11 (Table3).  13 
 14 
Characteristics of included reviews 15 
 16 
Table 2 summarises the characteristics of included reviews which were published between 2002 and 17 
2014, most (n=11) being published in, or after, 2008. Included reviews consisted of studies that involved 18 
meta-analyses
14,15,16,26,28,29
; meta synthesis
26
 and narrative reviews
7,17,18,19,20,21,22,23, 24,25,27,30
. One of the 19 
narrative reviews present the results by grade of evidence
137
 and another focuses on costs and cost 20 
effectiveness data of models across all care settings
18
. 21 
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 1 
Population, intervention, comparator and outcomes reported  2 
Heterogeneity is evident in the adult populations, interventions, comparators and outcomes found in 3 
the reviews (Table 2). All reviews consider one or more of the following; health service outcomes, 4 
patient outcomes and family or caregiver outcomes. Patient and caregiver outcomes relate to physical 5 
(e.g. physical symptoms), psychological (e.g. coping), social issues (e.g. place of care).  6 
The range of models of palliative care 7 
Models are often classified with reference to the setting in which they are delivered. Evidence 8 
frequently describes home based palliative care or models that are delivered across care settings (i.e. 9 
home, hospital, or inpatient hospice). Using descriptors of the models found in the included reviews for 10 
fidelity, these models have been clustered together as follows:  11 
1. home based palliative care
14, 15,16
 (i.e. models of palliative care delivered within the patient or 12 
ƚŚĞŝƌĐĂƌĞƌ ?ƐŽǁŶŚŽŵĞ ?,  13 
2. models delivered across multiple settings.  14 
Our approach to reporting on the models across settings is pragmatic due to the lack of detailed 15 
description of the models in the included publications. The ƚĞƌŵƐƵƐĞĚďĞůŽǁƚŽ ‘ĐůĂƐƐŝĨǇ ?ƚŚĞŵŽĚĞůƐ16 
reflect those used in the reviews themselves as it is not possible to develop a typology of models from 17 
the scant information available about these in the included reviews. It is not appropriate to re-define 18 
these  “ĐůƵƐƚĞƌƐ ?ĂƐƚŚŝƐŝŶǀŽůǀĞs making assumptions about the characteristics of the models identified. 19 
Therefore models in this review are 'clustered' according to the terms used to describe the models in 20 
the reviews themselves as this best reflects the focus of the included reviews as: 21 
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x palliative care 7,17,18 or a palliative care approach19. This includes palliative care for patients with 1 
HIV / AIDS
17
 and dementia
19
 and outpatient palliative care
20
 for patients with various diagnoses, 2 
including cancer, Congestive Heart Failure and Chronic Obstructive Pulmonary Disease 3 
delivered in non-hospice settings, including specialist consultations and co-management in 4 
clinics, in home or residential home settings.  5 
x specialised palliative care 21,22 for patients with various diagnoses or specialist palliative care for 6 
patients with cancer
23
 including hospice care
24
 (again, for patients with various diagnoses);  7 
x a team approach defined as models which provide an integrated team based approach to 8 
providing palliative care. Models are described as a palliative care team
27
 specialist palliative 9 
care team
26
; palliative and hospice care teams (PCHCT)
28
; an interdisciplinary team approach
25
; 10 
hospital-based palliative care teams
29
 or dedicated community teams
30
.  11 
Despite limitations in the reporting about models, it is clear that considerable heterogeneity exists in the 12 
models of palliative care and their components (Table 2). None-the-less, almost all models appear to 13 
involve some specialist palliative care provision (i.e. provision by delivery agents with training in 14 
palliative care), albeit that ƚŚĞůĞǀĞůŽĨƚŚĞĐĂƌĞƉƌŽǀŝĚĞƌƐ ?ƚƌĂŝŶŝŶŐŝƐŶŽƚĞǆƉůŝĐŝƚůǇƐƚĂƚĞĚŝŶĂůů15 
publications. Often, differences between the models are unclear and models are potentially 16 
overlapping. Included reviews report that models are often not well defined or described in original 17 
studies, which explains the paucity of subsequent reporting in reviews. A key limitation of the evidence 18 
base is the lack of descriptive detail provided about the models which makes it difficult to know how 19 
these have been conceptualised and to identify similarities and differences.  20 
 21 
The advantages and disadvantages of models of palliative care 22 
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Insights into causal pathways and mechanisms of action  are not evident in the evidence base. Reviews 1 
report a range of outcomes conceptualised and measured in different ways. This provides huge 2 
challenges in making comparisons across outcomes. The varied reporting of evidence (i.e. by outcome, 3 
study, setting or a combination of these) compounds difficulties in comparing review findings. The 4 
reporting of the individual models and components is too scant, and too variable for synthesis of 5 
findings about which components of palliative care models are most appropriate for different patient 6 
groups and under what circumstances across different reviews to be feasible.  None-the-less, it is 7 
possible to report on the advantages and disadvantages of models as reported in the reviews.  8 
 9 
Evidence for home based palliative care models 10 
Three reviews
14,15,16
 report specifically on home based models of palliative care for patients with 11 
advanced illness, including malignant and non-malignant conditions (Table 2). Positive benefits of 12 
palliative home care services over comparator models (which varied) are reported (see Table 2). The 13 
benefits include an increased likelihood of dying at home, as identified in two meta-analyses
14,16
. A third 14 
meta-analysis
15
 reports inconclusive, but compelling trends in the evidence in favour of home services 15 
increasing home deaths without compromising symptoms, QoL or costs compared to other models that 16 
did not include access to home nursing.   17 
 18 
 19 
Evidence for models of care involving provision across different settings:  20 
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One review
18
 specifically reports on the costs and cost effectiveness of palliative and / or hospice care 1 
interventions in any setting (i.e. hospital-based, home-based and hospice care). This review includes 2 
home, hospital and hospice based palliative care and therefore appears in more than one section below. 3 
The remaining fourteen reviews
7,17,19,20,21,22,23,24,25,26,27,28,29,30 
report on a range of heterogeneous 4 
intervention and comparator models of palliative care which have been implemented across a range of 5 
contexts and settings. 6 
Additionally, the heterogeneity of these models, the limited volume of evidence relating to each service 7 
model and the diverse reporting of findings across reviews makes synthesis difficult.  Reviews report 8 
findings with reference to the outcomes measured
7,14,15,16,18,22,23,25,30  
both interventions and outcomes
29
 9 
or outcomes and themes identified
24
; method of analysis
28,
 evidence grade
17
, setting
26, 27
, study
19,20, 21
 or 10 
study type
 26
.  11 
 12 
 ?Palliative care or a palliative care approach, including outpatient palliative care ?:  13 
Four reviews
7,17,19,20
 report some evidence suggesting that palliative care reduces total healthcare costs, 14 
with one review suggesting there is reduced healthcare utilization and a lengthening of survival for 15 
patients with lung cancer
20
. Evidence from high quality RCTs indicate a reduction in direct costs for 16 
programmes including home care with Palliative Care Team (PCT) support compared to usual care
7
.  17 
Home care programmes also reduce the need for acute hospital care
7
. Harding et al (2005)
17
 and 18 
Sampson et al (2005)
19
 provide scant evidence to support their conclusion, possibly due to limitations in 19 
the reporting of this data in primary studies. None-the-ůĞƐƐ ?^ŵŝƚŚĞƚĂů ?Ɛ ? ? ? ? ? ?18 more detailed findings 20 
which focus on the costs of palliative care concur with these reviews, indicating that, in most cases, 21 
palliative care is consistently found to be significantly less costly than comparator models. However, 22 
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Smith et al (2014)
18
 acknowledge that their findings are based on variable cost data that often fails to 1 
consider  ‘out of pocket expenses ? or informal care costs. The evidence base for cost-effectiveness is very 2 
limited as Smith et al (2014)
18
 report on only one cost effectiveness study, the results of which are 3 
ŝŶĐŽŶĐůƵƐŝǀĞ ? dŚŝƐ ĨŝŶĚŝŶŐ ĐŽŶĨŝƌŵƐ ƌŽƌĂ Ğƚ Ăů ?Ɛ  ? ? ? ? ? ?7 conclusions that the cost-effectiveness of 4 
palliative care has not been rigorously assessed.  5 
Three reviews
7,17,20
 conclude that there are benefits or trends indicating some benefits of palliative care, 6 
including an increase in patient and family / caregiver satisfaction
 
and improvements in symptom 7 
control. Rabow et al (2013)
20
 also report that outpatient palliative care services improve clinician 8 
satisfaction.  ,ĂƌĚŝŶŐĞƚĂů ?Ɛ ? ? ? ? ?) review17 reports data that patients with HIV / AIDS receiving home 9 
care value the emotional support and high quality of care received, as well as being able to remain at 10 
home and avoid hospital visits which was less disruptive of their daily routine. This review
17 
also 11 
suggests that both home and inpatient hospice care significantly improved anxiety, insight and spiritual 12 
wellbeing.  Only Arora et al (2011)
7
 reports on place of death, finding inconclusive results in terms of 13 
whether patients died at home or not. This review
7 
also reports little evidence of benefits for patient 14 
survival, quality of life, patient satisfaction and resource use.  A fourth
19 
review concludes that there is 15 
insufficient evidence to indicate benefits of a palliative care approach for patients with dementia. None 16 
of these four reviews
7,17,19,20
 found evidence to suggest that palliative care worsens patient or caregiver 17 
outcomes. 18 
Specialised or specialist Palliative Care including models of hospice care:  19 
Four reviews
21,22,23,24 
report on specialised or specialist palliative care, including models of hospice care.  20 
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Three of these reviews report on the costs of specialist or specialised palliative care
21,22,24
. Although 1 
limited cost data exist, reviews concur that the models are associated with cost savings, usually due to a 2 
reduction in general health care use
24,
, emergency care use
24
, hospital costs (although this review also 3 
reports that home and hospice care costs increased when patients were referred to a palliative care 4 
programme)
22
 and inpatient stays
21
. Smith et al (2014)
18 
report that cost savings associated with 5 
palliative care are largely due to significant differences in hospital readmission rates compared to 6 
ƉĂƚŝĞŶƚƐ ƌĞĐĞŝǀŝŶŐ  ‘ƵƐƵĂů ĐĂƌĞ ? ? ,ŽǁĞǀĞƌ ? ŝƚ ŝƐ ŶŽƚ ĐůĞĂƌǁŚĞƚŚĞƌ ƚŚĞ ĐŽƐƚ ƐĂǀŝŶŐƐ ĂƌĞ ĂƚƚƌŝďƵƚĂďůĞ ƚŽ7 
ƐƉĞĐŝĂůŝƐƚƉĂůůŝĂƚŝǀĞĐĂƌĞŝŶ^ŵŝƚŚĞƚĂů ?Ɛ ? ? ? ? ? ?18 review.  8 
 9 
Although Candy et al (2011)
24
 found that hospice care delivered at home increases death not occurring 10 
in hospital, effective pain relief and patient and family satisfaction with care, reviews of other 11 
specialised palliative care services do not concur with these findings.   Garcia-Perez et al (2009)
21
 found 12 
that all reviews conclude that no specific model of  specialised palliative care  is more effective or cost 13 
effective than others with regard to symptom control, QoL, emotional support and satisfaction. 14 
Zimmermann et al (2008)
22
 concur with Garcia-Perez et aů ?Ɛ ? ? ? ? ? ?21 findings for symptom control, QoL 15 
and patient satisfaction, but report consistent improvements  in family satisfaction with specialised 16 
palliative care. Candy et al (2011)
24 
concur reporting an increase in patient and family satisfaction when 17 
hospice care is ƉƌŽǀŝĚĞĚ ŝŶĂǀĂƌŝĞƚǇŽĨ ƐĞƚƚŝŶŐƐ ŝŶĐůƵĚŝŶŐŚŽƐƉŝƚĂů ?ŶƵƌƐŝŶŐŚŽŵĞŽƌĂƉĂƚŝĞŶƚ ?ƐŚŽŵĞ ?18 
Qualitative  findings in their review
24
  also suggest that hospice care is highly valued by patients and 19 
families, whist hospice day care generates a renewed sense of meaning and purpose for patients. Home 20 
hospice services support families to sustain patient care at home.  21 
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Davies and Higginson, (2005)
23 
also identify some advantages of specialist palliative care day services in 1 
terms of high patient satisfaction and the value of social contact with staff and other patients. 2 
 3 
 4 
Palliative Care Teams:  5 
 6 
Six reviews report on palliative care teams
25,26,27,28,29,30
. Although one meta synthesis reports wide 7 
variations in the type of service delivered by such teams, there is no discernible difference in outcomes 8 
between service delivery in cities, urban, and rural areas and evidence of benefit is strongest for home 9 
care
24
. Multidisciplinary teams are found to be more effective than unidisciplinary teams in one 10 
review
27
. 11 
 12 
Although five reviews 
26,27,28,29,30
 all identify some advantages of team based models of palliative care in 13 
terms of effectiveness, one review based on four studies of varying quality reports little evidence to 14 
support the effectiveness of interdisciplinary teams
25
. In terms of specific outcomes, a team approach is 15 
found to improve pain and symptom control
26,27,28,29,30
 and reduce anxiety in some cases
26
. Additionally, 16 
although some reviews report mixed findings about satisfaction
29,30
, most report that palliative care 17 
teams increase patient
25,27
and especially carer satisfaction
27,28,30
, with one not specifying whether 18 
satisfaction increases for patients, carers or both groups
26
.   19 
 20 
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Reviews suggest that the impact of palliative care teams on home deaths was equivocal
28
 but hospice at 1 
home teams lead to more home deaths and fewer deaths in nursing homes
30
.  Although one review 2 
indicates no differences in hospital use, others suggest that specialist palliative care teams have 3 
advantages in terms of reducing hospital admissions and length of hospital stays
26,27
.  One review 4 
reports that home hospice reduces costs
27
. Cost savings are attributed to transfer of costs from hospital 5 
to home in one review
29 
and differences in length of stay in another review
28
. Smith et al (2014)
18 
6 
support the latter finding reporting that the average length of stay was significantly shorter for palliative 7 
care patients compared to the control group.  8 
 9 
Evidence for the effectiveness, cost-effectiveness and appropriateness of the different models of 10 
palliative care for different patient groups in different contexts 11 
Heterogeneity and methodological limitations make it impossible to identify the relative advantages and 12 
disadvantages of different models for different patient groups or in different contexts.  However, all 13 
reviews highlight a number of potential advantages and relatively few disadvantages for all models of 14 
palliative care. Although all reviews identify the delivery agent(s) and care recipients, few details are 15 
given about delivery mechanisms or the context and settings, timing, duration and circumstances in 16 
which models are delivered.  Comparator models aƌĞŽĨƚĞŶĚĞƐĐƌŝďĞĚĂƐ ‘ƵƐƵĂůĐĂƌĞ ?ďƵƚŵĂŶǇƌĞǀŝĞǁƐ 17 
provide no further detail about the components of these models, meaning that it is not possible to 18 
determine which components of the models may influence outcomes.  19 
 20 
Discussion  21 
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The publications included in this systematic review of review level evidence report a range of 1 
heterogeneous models of palliative care in terms of their definitions, descriptions, components and 2 
outcome measures. Most reviews relate to specialist palliative care services, defined as those delivered 3 
by staff working primarily in palliative care and with training in this speciality. Irrespective of setting or 4 
patient group, models of palliative care included in the reviews appear to show potential benefits for 5 
patients and their carers, with no evidence of negative effects. There is some evidence to suggest that 6 
some models may result in reduced total healthcare costs. 7 
The heterogeneous nature of the interventions across the various care settings means that there is little 8 
evidence at review level relating to relevant settings such as  nursing homes
31
. No reviews examining 9 
palliative care for people with mental health issues or learning disabilities, who have specific needs and 10 
preferences 
35,36
 were identified.  11 
 ‘hƐƵĂů ? ? ‘ƐƚĂŶĚĂƌĚ ?Žƌ ‘ĐŽŶǀĞŶƚŝŽŶĂů ?ĐĂƌĞŝƐŽĨƚĞŶĂĐŽŵƉĂƌĂƚ ƌŵŽĚĞůďƵƚŶŽƚǁĞůůĚĞĨŝŶĞĚŽƌĚĞƐĐƌŝďĞĚ12 
and likely to vary considerably between countries given international differences in conceptualisations 13 
of palliative care
32
.  The lack of detailed descriptions of both interventions and comparators at review 14 
level may result from reporting restrictions (e.g. word limitations). However, the limited description of 15 
models makes it difficult to discern differences between models of palliative care and draw firm 16 
conclusions from our review, especially as we cannot be certain that there are no overlaps in the way 17 
models have been  ‘ĐůƵƐƚĞƌĞĚ ?ŝŶƚŚŝƐƌĞǀŝĞǁ.  Consequently, it was also difficult to draw conclusions 18 
about the efficacy of the individual components of any model. In common with other reviews of review 19 
level evidence that focus on models of palliative care
7,33
 heterogeneity in the study designs, populations, 20 
interventions and outcomes of the included reviews precluded meta-analysis and meta synthesis.   21 
 22 
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Hoffman et al (2014)
34 
offer suggestions about how better reporting of interventions can be achieved 1 
using the 12 item template for intervention description and replication (TIDieR) checklist and guide, an 2 
extension of the CONSORT 2010 statement (item 5)
31
 and the SPIRIT 2013 statement (item 11)
36
. 3 
Developed for the reporting of all types of evaluative studies, the TIDieR checklist
34
 could also be used 4 
when reporting on interventions in systematic and narrative reviews.  Although the TIDiER checklist
34
 5 
prompt authors to describe interventions in enough detail to enable replication, the guidelines highlight 6 
issues that caused difficulty within this review. For example, in addition to the limited reporting about 7 
their components, models are not easy to find or recognise as few are known by specific names or 8 
described in a manner that allows identification. The lack of detail about the aim, rationale and the 9 
components of models reported in reviews perhaps reflects the lack of attention that has been given to 10 
the theoretical underpinning of these complex interventions
3
. The lack of conceptual underpinning for 11 
models may also explain the recognised variation in the outcomes measured
37
. Some work to explain 12 
the mechanisms of action and causal pathways of the models developed and evaluated is fundamental 13 
to successfully determining what is likely to be effective
8
. Indeed, the complex nature of palliative care 14 
and the difficulties in identifying which components, if any, are important and has been recognised by 15 
McQuay (2011)
38
.  16 
 17 
Outcome reporting is also a key issue to address in palliative care practice and research
37,39
 especially in 18 
the evaluation of complex interventions
40 
such as models of care where there is a need to explain 19 
mechanisms of action
41
 and identify how these relate to intermediate and final outcomes
40
.  Diverse 20 
outcomes are assessed for patients, family members and caregivers, staff members and professionals in 21 
palliative and hospice care using a wide range of assessment instruments in published studies
37
. 22 
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Agreement about important outcomes and consistency in outcome measures is essential if national and 1 
international comparisons are to be made in the evaluation of palliative care services
39
. However, 2 
irrespective of the well documented methodological challenges of outcome measurement in palliative 3 
care
37
, consensus will not be easy to establish, especially as the outcomes of interest are likely to vary 4 
among stakeholders and levels (i.e. individual, family, community, societal).  The EAPC (2015)
39
 5 
recognise outcome measurement as key to understanding different models of care and recommend the 6 
introduction of outcomes that allow for national and international comparisons.   7 
 8 
Comparison with findings of previous reviews of palliative care models:  9 
 10 
The findings of our review are consistent with those reported in other reviews of review level 11 
evidence
7,33,42,43
, despite differences in the scope and methods used. Both Luckett et al (2014
)33
 and 12 
Arora et al (2011)
7 
completed both a review of reviews and a review of primary studies undertaken by a 13 
single researcher respectively.  Our review included any type of review and any outcome, whereas Arora 14 
et al (2011)
7
 limited the review to eight commonly reported outcomes. The limitation of ƌŽƌĂĞƚĂů ?Ɛ15 
(2011)
7
 inclusion criteria seems ĂƉƉĂƌĞŶƚŐŝǀĞŶƚŚĂƚ^ƚŝĞůĞƚĂů ?Ɛ ? ? ? ? ? ?37 systematic review reported the 16 
existence of over 500instruments to measure outcomes. However, our findings indicate that the 17 
outcomes selected by Arora et al (2011)
7
 are those most frequently reported. In keeping with our 18 
findings, Keirse et al (2009)
43
 found that most evidence relates to home models of palliative care (taking 19 
into account that home models are included in some models provided across settings), and conclude 20 
that heterogeneity in terms of the aims, caregivers, target populations and interventions make it 21 
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difficult to compare models with regard to cost-effectiveness . In keeping with others
7,33
, we found poor 1 
quality information and a general lack of reporting about the components of the various types of 2 
models. The difficulties associated with synthesising data about disparate models of palliative care has 3 
also been previously acknowledged
20,22
.    4 
 5 
Quality of included reviews and primary studies:   6 
The generally weak quality of evidence of the primary studies on which the included reviews were based 7 
is largely due to the well documented methodological challenges faced by researchers within the field of 8 
palliative care
3,44,45
.  These methodological difficulties consequently impact on the quality and 9 
usefulness of reviews in palliative care
46
. None-the-less, Wee et al (2008)
46
 acknowledge that reviews 10 
can inform the palliative care community about the limited evidence base and indicate deficiencies in 11 
the primary evidence base.  The lack of  controlled trials in palliative care makes use of findings from 12 
well-designed nonrandomized controlled trials inevitable.
47
.  13 
Strengths and limitations of this review of reviews  14 
Restriction to English language searches introduces a potential bias
48, 
as does the mainly UK focus of the 15 
grey literature searches. The broad aims and the inclusion of all outcomes in an attempt to provide 16 
a comprehensive review of reviews may have generated additional challenges in terms of data 17 
analysis and reporting. However, despite ensuring that the Amstar criteria
7
 for a high quality review 18 
are met, this review is also weakened by the poor reporting of heterogeneous models of palliative care 19 
and the lack of standardised outcome measures, a known problem in the field of palliative care
37
.  20 
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PŽŽƌƌĞƉŽƌƚŝŶŐŵĂŬĞƐƚŚĞĚĞǀĞůŽƉŵĞŶƚŽĨĂƚǇƉŽůŽŐǇŽĨŵŽĚĞůƐŝŵƉŽƐƐŝďůĞ ?ůƚŚŽƵŐŚ ‘ĐůƵƐƚĞƌŝŶŐ ?ŵŽĚĞůƐ1 
provides some consistency of reporting between included reviews and our own, models are potentially 2 
overlapping  as similarities and differences between models are not clear. Consequently, we cannot be 3 
sure of the effect that these clusters may have on the reporting of relevant outcomes. Irrespective 4 
of the clustering, it is evident that all reviews highlight some advantages of models and very few 5 
limitations.  6 
The differences in palliative care provision between countries and contexts means that models vary  7 
considerably, making comparisons difficult. The wider generalisability of the review to low or middle 8 
income countries is limited, since the evidence originates from largely high income countries where 9 
populations are rapidly ageing and more is spent on health care
46
.  A mapping review shows  a paucity of 10 
research in international palliative care, and particularly highlights a lack of research from low to middle 11 
income regions
49
.  This lack of evidence, combined with complexities in transferring evidence from 12 
different contexts, means that cross-country comparisons are likely to remain challenging.  13 
Implications for policy and practice   14 
This review of reviews shows a substantial body of evidence which, overall, supports the development 15 
and implementation of a range of different models for providing palliative care, across different settings 16 
and for different clinical conditions and patient groups. However, it remains difficult to conclude which 17 
models may be the most effective, cost-effective and appropriate to different contexts and therefore 18 
such decisions will still be largely based on the preferences of local providers and commissioners and the 19 
availability of the required staff, resources and facilities. 20 
Implications for research 21 
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Better reporting of interventions and comparators in primary research is likely to subsequently increase 1 
the value of systematic reviews in terms of providing the best evidence
50
, improving the standard of 2 
evaluative research
3 
(especially as Randomised Controlled Trials (RCTs) are often inadequate in palliative 3 
care
51
), better understanding complexity
8
, mechanisms of action and critical components of models of 4 
care.  5 
Conclusions 6 
A range of models of palliative care are reported in mainly medium to high quality published review 7 
evidence, most of which are narrative reviews based on non-randomised studies. Most available 8 
evidence relates to home care. Reviews highlight a number of potential advantages and few 9 
disadvantages of models of palliative care. However, the heterogeneous nature and the poor quality of 10 
reporting about the components of the models makes it difficult to draw any conclusions about which 11 
models are most appropriate in different contexts or for different patient groups. The under-reporting 12 
of the components of intervention and comparator model is a major barrier to the evaluation and 13 
implementation of models of palliative care.   14 
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 1 
Box 2   Search Terms 2 
 3 
 Search Terms 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
Advance care planning/ 
Attitude to death/ 
Bereavement/ 
Death/ 
Hospices/ 
Hospice Care/ 
Palliative care/ 
Right to die/ 
Terminal care/ 
Terminally ill/ 
1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 
(Attitude$ adj2 (death$ or dying or care or caring)).ti,ab. 
Bereave*.ti,ab. 
(EOL or end of life).ti,ab. 
Hospice*.ti,ab. 
(Imm* adj2 death).ti,ab. 
(Incurabl* adj2 ill*).ti,ab. 
(Limit* adj2 life).ti,ab. 
Palliat*.ti,ab.) 
((Respite or support*) adj2 (care or caring)).ti,ab. 
(Terminal and (care or caring or ill* or disease*)).ti,ab. 
12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 
11 or 22 
MEDLINE.tw. 
Systematic review.tw. 
Meta-analysis.pt. 
Intervention$.ti. 
24 or 25 or 26 or 27 
23 and 28 
Limit 29 to (English language and humans and yr="2000 - 2014") 
4 
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 1 
Table 1: Inclusion criteria: 2 
Inclusion Exclusion  
Study type: Review level evidence reporting 
models of palliative care. Publications reporting 
systematic reviews of all types of original study 
(intervention, observational and qualitative 
studies). Reviews of reviews will be included 
when  
the findings related to the primary studies can 
be considered independently of the review of 
review findings in the publication.  
 
Publications that are not review level 
evidence (i.e. primary studies). Publications 
or reviews that are not systematic in 
evidence search, retrieval appraisal, 
synthesis and analysis  
Opinion papers, editorials and conference 
abstracts.  
 
Dates: Systematic & narrative reviews 
published between 2000- 2014.  
 
Dates: Systematic & narrative reviews 
published outside of the date range 2000- 
2014.  
Population: Reviews considering adults 
(defined as people aged 18 and over) with life-
limiting illnesses as defined by the study 
authors. Reviews considering populations of 
varying ages will be included providing the 
focus of the research is adults, not children or 
adolescents.  
Reviews solely considering children and 
adolescents (defined as those aged under 
18 years of age).. 
 
Intervention: Reviews considering models of 
palliative care for any palliative care patient 
group.  
Reviews will be excluded if focus is not a 
model of palliative care or is a single 
intervention used in palliative care.  
Models of palliative care provided at 
specific phases of the disease trajectory 
(e.g. bereavement services only). 
 
Comparator: Any model of palliative care 
(specialist or generalist) provided at any point 
in the disease trajectory (i.e. from diagnosis to 
death) OR any form of   ‘ƵƐƵĂů ?Žƌ ‘ƌŽƵƚŝŶĞ ?ĐĂƌĞ ?
There may be no comparator.  
We did not exclude reviews based on the 
comparator 
Outcomes: All outcomes that are reported will 
be examined.  
We did not exclude Reviews based on 
outcomes reported.  
Language: written in English.  Language: Reviews not written in English,  
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 1 
Figure 1: PRISMA flowchart 2 
 3 
 4 
 5 
 6 
 7 
 8 
  9 
 10 
 11 
 12 
  13 
 14 
 15 
16 
8799 Records did not meet the inclusion criteria. Most were not 
reviews of models of palliative care; many focused on process 
models of palliative care (e.g. Gold Standard Framework / Liverpool 
Care Pathway) 
467 full texts assessed for 
eligibility  
454 Records did not meet the inclusion criteria. Most were not 
evaluations of models of palliative care (e.g. focusing on staff or 
patient views and experiences of care in a particular setting).  
 
Electronic search 
n= 17241 
Removed duplicate records n= 7975 
Records screened (titles / abstracts)  ? 
9266 
4 Additional records
 
from searching references of included reviews 
18 records included  
1 record
5
 found during scoping prior to electronic searches met the 
inclusion  
13 records included  
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Table 2: Characteristics of included reviews: 
Author, year, country 
or origin  type of 
review & AMSTAR 
score 
Review question/aim Type and number of 
studies included 
Population Intervention Comparator 
model(s) 
Or none 
Primary Outcome Key conclusions 
HOME SETTING 
Gomes et al  
2013
14
 
UK  
 
Cochrane systematic 
review & meta 
analysis where 
appropriate. 
 
AMSTAR score - 11 
To evaluate the 
impact of home 
palliative care services 
on outcomes for 
adults with advanced 
illness or their family 
caregivers or both. 
Included controlled 
intervention studies. 
Identified 23 studies 
in 84 records 
Adults with terminal 
illness, their family 
carers or both in 
receipt of home 
palliative care 
services 
Home palliative care 
ĂŶĚ ‘ƌĞŝŶĨŽƌĐĞĚ ?ŚŽŵĞ
palliative care (i.e. with 
an additional 
component of carer 
support) 
 ‘ 
  
hƐƵĂůĐĂƌĞ ?defined 
in various ways 
(comparator for 
Home palliative 
care) 
 
Care from 
specialist palliative 
care teams 
(comparator for 
 ‘ƌĞŝŶĨŽƌĐĞĚ ?ŚŽŵĞ
palliative care). 
Death at home Home palliative care 
more than doubles 
the odds of dying at 
home 
Luckett  et al  
2013
15 
Australia  
 
Systematic review & 
meta analysis   
 
AMSTAR score - 9 
 
To compare the effect 
of Specialist Palliative 
care Services (SPCSs) 
providing home 
nursing vs. other 
models of service 
delivery on rates of 
home deaths.  
 
 
Included comparative 
studies of any design 
that used 
quantitative 
evaluation. Identified 
9 studies in 10 
records.   
 
 
Patients with life 
limiting illnesses;  
receiving nursing 
care exclusively at 
home.  
 
Interventions delivering  
nursing care exclusively 
in the home rather 
than only through a day 
hospital or inpatient 
services. 
 
an alternative that 
did not include 
access to home 
nursing. 
  
Rates of home deaths  
 
  
 
Inconclusive evidence 
that community SPCSs 
offering home nursing 
increase home deaths 
without 
compromising 
symptoms, QoL or 
increasing costs 
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Shepperd et al  
2011
16 
UK 
 
Cochrane systematic 
review & Meta 
analysis / narrative 
summary where mata 
ʹanalysis not possible 
 
 
AMSTAR score - 11 
 
To determine if home-
based end of life care 
reduces the likelihood 
of dying in hospital 
and what effect this 
ŚĂƐŽŶƉĂƚŝĞŶƚƐ ?
symptoms, quality of 
life, health service 
costs anĚĐĂƌĞŐŝǀĞƌ ?Ɛ
satisfaction compared 
with inpatient hospital 
or hospice care. 
 
Included controlled 
intervention studies. 
Identified 4 trials.  
 
 
Adults aged 18  with 
various diagnoses 
and over who 
require terminal care 
at the end of life.   
 
End of life care at home  
Inpatient hospital 
or hospice care 
 
Place of death 
WĂƚŝĞŶƚƐ ?ƉƌĞĨĞƌƌĞĚ
place of death 
 
Patients receiving 
home-based end of 
life care were more 
likely to die a home 
compared with those 
receiving usual care 
(p=0.0002).  
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ACROSS SETTINGS: PALLIATIVE CARE OR A PALLIATIVE CARE APPROACH 
 
Arora et al  
2011
7 
New Zealand  
 
Part 2  ? Narrative  
review of original 
studies  
 
AMSTAR score - 7 
 
To compare the 
efficacy of different 
models of palliative 
care  
 
 
Included adequately 
powered comparative 
studies.Identified 27 
eligible studies 
eligible studies in 34 
records.   
 
 
Adult palliative care 
patients as defined 
by the NZ Palliative 
Care Strategy (2001). 
Most had advanced 
cancer.  Some study 
populations focused 
on family members / 
carers.  
 
Any international 
structures, programs, 
systems or models 
of palliative care from 
different settings. 
 
 
Any alternative 
structure, 
program, system 
or model of 
palliative care 
(including no 
structured 
program). 
 
A  range of outcomes 
including: 
1. Patient quality of life 
2. Patient satisfaction 
3. Symptom control 
4. Caregiver satisfaction 
5. Place of death 
6. Survival 
7. Utilisation of 
resources 
8. Cost of care 
 
Heterogeneous 
models of palliative 
care with inconsistent 
results were found. 
Little evidence of 
benefits in favour of 
the intervention for 
home deaths, patient 
survival, quality of life, 
patient satisfaction 
and resource use. 
Home-care 
programmes reduced 
the need for acute 
hospital care. Some 
high-quality RCTs 
reported reduced 
costs for home care 
programs with PCT 
support.  
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Harding et al  
2005
17 
UK   
 
Narrative review 
presented by evidence 
grade 
 
AMSTAR score - 6 
 
To appraise the effect 
of models of palliative 
care on patient 
outcomes.  
 
Included original 
research of any 
design.  
Identified 22 services 
that had in 17 
records. 
 
 
Population infected 
with any stage of HIV 
/ AIDS (or 
HIV infected 
subsample analysed 
and reported 
separately).  
 
 
Home based care; home 
palliative care/hospice 
at home; hospice 
inpatient; hospital 
inpatient palliative care; 
specialist AIDS inpatient 
unit; and hospital 
inpatient and 
outpatient care. 
 
 
Not  stated 
 
Various outcomes 
measured including pain 
and symptom control, 
patient and family 
anxiety, patient and 
family insight, 
communication and 
spiritual well-being..  
Satisfaction with care, 
medical procedures and 
investigations, 
perceived quality of 
care, patient 
involvement, support, 
and quality of life. 
 
Both home palliative 
care and inpatient 
hospice care 
significantly improved 
pain and symptom 
control, anxiety, 
insight, and spiritual 
wellbeing. 
 
Sampson et al.  
2005
19
  
UK  
Narrative review 
presented by study 
 
 
AMSTAR score - 5 
 
A systematic review 
assessing the efficacy 
of a palliative care 
model in patients with 
dementia. 
 
Included any 
evaluative study 
design.  
Identified 2 studies- A 
randomized control 
trial & a prospective 
cohort study 
 
Adults with a 
diagnosis of 
dementia. 
 
Palliative care - 
Dementia Special Care 
Unit and an unidentified 
intervention in the 2
nd
 
study. 
 
 
Dementia Special 
Care Unit 
compared to 
traditional long-
term care 
comparator not 
stated in the 2
nd
 
study 
  
Patient discomfort, 
medical resource 
utilization and mortality 
rates.  
 
Equivocal (uncertain) 
evidence of the 
efficacy for a palliative 
model of 
care in dementia. 
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Rabow et al 2013 
20 
 
UK  
 
Narrative review 
presented by study 
 
AMSTAR score - 5 
 
To assess the evidence 
of the impact of non-
hospice outpatient 
palliative care services 
(defined as including 
specialty consultations 
and co-management in 
clinics, homes, 
or residential living 
facilities) 
 
 
Included prospective, 
randomised 
controlled  
trials. Identified 4 
studies.  
 
 
Patients with late 
stage COPD, CHF and 
cancer; advanced 
cancer and 
metatastic non-small 
cell lung cancer and 
their family 
caregivers. 
 
Outpatient palliative 
care services for 
terminally ill patients 
(i.e. in outpatient clinics, 
primary care clinics; in 
home or via telephone).  
 
 
Usual care which 
included usual 
primary care and 
usual oncology 
care. Usual care 
was not described.  
 
 
Impact of outpatient 
palliative care on  
patient, family 
caregiver, and clinician 
satisfaction; clinical 
outcomes including 
symptom management, 
quality of life, and 
mortality; and heath 
care utilization 
outcomes.  
 
Outpatient palliative 
care services can: 
improve patient 
satisfaction, symptom 
control and quality of 
life.  These services 
also reduce health 
care utilization& costs 
and lengthens survival 
in lung cancer 
patients.   
Family and clinician 
satisfaction improved.  
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ACROSS SETTINGS: SPECIALIST PALLIATIVE CARE & HOSPICE 
 
Garcia-Perez et al.  
2009
21
 
Spain.  
 
 
Narrative review 
presented by study.  
 
 
AMSTAR score - 6 
 
To  assess & synthesise 
evidence on the 
effectiveness and cost 
effectiveness 
of specialised palliative 
care for terminally ill 
patients, comparing 
different 
organisational models 
with one another. 
 
Included comparative 
study designs 
examining two or 
more specialised 
palliative care 
programmes in adults 
with terminal illness. 
Identified 2 studies.  
 
Adults (18 years and 
older) with terminal 
illness included in a 
palliative care 
programme. 
 
Specialised palliative 
care programmes 
(i.e. Full palliative care 
team; Telephone 
palliative care team; In 
patient and home 
hospices and specialist 
palliative care unit). 
 
Comparing 
different 
organisational 
models of 
specialised 
palliative care 
provision with each 
other. 
 
Pain and other 
symptom control, 
psychological 
symptoms, health-
related quality 
of life, well-being, 
functional state, 
satisfaction, place 
of death, number of 
patients cared, number 
of home visits, number 
of days at hospital.  
 
None of the 
programmes studied 
are more effective (in 
terms of symptom 
control, QoL, 
emotional support or 
satisfaction) or cost-
effective than 
another.  
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Zimmermann et al.  
2009
22
.  
Canada  
 
 
Qualitative narrative 
synthesis.  
 
 
 
AMSTAR score - 8 
 
To  systematically 
examine the evidence 
for the effectiveness of 
specialized palliative 
care in improving 
quality of life, 
satisfaction with care, 
and economic 
cost. 
 
Included randomised 
controlled trials.  
Identified 22 records.  
 
Population with 
mixed diagnoses 
including cancer, 
COPD, Congestive 
Heart Failure (CHF) 
Motor Neurone 
Disease & AIDS  
 
 
A specialized palliative 
care service was defined 
as a service of 
professionals that 
provides or coordinates 
comprehensive care for 
patients with a terminal 
illness. 
  
 
 ‘hƐƵĂůĐĂƌĞ ?ŝŶĂ
variety of settings.  
 ‘^ƚĂŶĚĂƌĚ ?ŚŽƐƉŝƚĂů ?
hospice or home 
care.  
Mailed self help 
materials. 
Office care; 
Telephone 
consultation or 4 
week waiting list. 
 
Patient or caregiver 
quality of life, 
satisfaction 
with care, or economic 
cost.  
(Quality-of-life measures 
were not specific for 
terminally ill patients.) 
 
Little evidence for 
benefit with regard to 
quality of life, 
symptom control and 
patient satisfaction or 
cost. However, 
specialized palliative 
care (SPC) consistently 
improves family 
satisfaction with care.  
 
Davies & Higginson   
2005
23
. 
 
UK 
 
Systematic review  
quantitative and 
qualitative analysis. 
 
 
 
AMSTAR score - 4 
 
To  systematically 
review the evidence 
for how the structure 
and process of 
palliative day  care 
relate to outcomes for 
adults with cancer. 
 
Included qualitative 
and quantitative 
studies examining the 
outcomes of interest.  
Identified 12 records. 
 
 
Adults with cancer.  
 
Specialist palliative day-
care  
 
Where stated, 
 ‘ƵƐƵĂůƉĂůůŝĂƚŝǀĞ
care (not defined) 
 
Symptom control, 
quality of life, social and 
psychological support, 
and patient and relative 
satisfaction with  
care 
 
Patient satisfaction is 
high among those 
attending day-care. 
No model of care was 
found to be better 
than any other in 
terms of outcomes. 
Patients seem to value 
the social contact with 
staff and other 
patients that day care 
visits provide.  
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Candy et al  
2011
24 
UK  
 
Systematic review  
quantitative and 
qualitative analysis 
 
 
 
AMSTAR score - 8 
 
To identify evidence 
for the effectiveness, 
including cost-
effectiveness, of 
hospices, and hospice 
ĐĂƌĞŝŶĂƉĂƚŝĞŶƚ ?Ɛ
home and in nursing 
homes and for the 
experiences of those 
who use and of those 
who provide such 
services. 
 
Included quantitative 
comparative study 
designs for evaluation 
of effectiveness and 
qualitative thematic 
evaluations to 
identify patient, 
family and  service 
ƉƌŽǀŝĚĞƌƐ ?ĞǆƉĞƌŝĞŶĐĞ
of 
hospice type services.  
Identified 22 records. 
 
Patients with a 
variety of cancer and 
non-cancer diagnoses 
in the final phases of 
terminal disease and 
family caregivers or 
family members. 
 
Hospice (defined as 
holistic provision to 
patient and family by 
MDT at a dedicated 
hospice facility) at home, 
in a nursing home or 
other care facility in the 
community 
 
 
 
Usual generalist 
care for 
comparative 
studies  
 
Symptom management, 
pain assessment and 
other aspects of patient 
care, satisfaction with 
services, family carer 
well-being such as care 
burden and 
bereavement /grief, 
health service use, costs, 
and place of death, 
ƉĂƚŝĞŶƚƐ ?ĞŵŽƚŝŽŶĂů
well-being  
 
 
 
Quantitative 
evidence shows that 
hospice care reduces 
general health service 
use and costs, and 
increases effective 
pain relief, death not 
occurring in hospital 
and patient and family 
satisfaction with care  
 
Qualitative findings 
suggest that hospice 
care is highly valued 
by patients and 
families.Home hospice 
services support 
families to sustain 
patient care at home. 
Hospice day care 
services generate a 
renewed sense of 
meaning and purpose 
for patients. 
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ACROSS SETTINGS: TEAM APPROACH 
 
Leclerc  et al  
2014
25 
Canada  
 
Narrative review  
 
 
AMSTAR score - 9 
 
To determine the 
effectiveness, harms 
and adverse effects of 
the interdisciplinary 
team approach to 
providing end of life 
palliative care to adult 
patients and their 
home caregivers 
compared to other 
approaches.  
 
 
Included 
comparative studies 
of any quantitative 
or qualitative design.  
Identified 4 studies 
in 5 records. 
 
 
In-patients or 
community dwelling 
patients aged 18 or 
over with stage III or 
IV cancer or a 
terminal condition 
with a prognosis of 
a year or less to live 
who received care 
in any setting.  
 
 
  ‘/ŶƚĞƌĚŝƐĐŝƉůŝŶĂƌǇ ?ƚĞĂŵƐ
or  interventions  
 
A group that did 
not receive care 
from an 
interdisciplinary 
team.  
 
 
Outcomes relate to 
patients, patienƚƐ ?ĨĂŵŝůǇ
members, home 
caregivers, healthcare 
providers or the 
healthcare system as 
well as adverse effects 
related to y aspect.. 
 
Interdisciplinary 
palliative care teams 
ĐĂŶŝŵƉƌŽǀĞƉĂƚŝĞŶƚƐ ?
satisfaction with 
palliative care, 
hospital care and 
health pƌŽǀŝĚĞƌƐ ?
communication 
Patients were 
satisfied with the 
chances of dying at 
home and were less 
likely to visit the 
emergency 
department or be 
hospitalised.  
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Higginson & Evans  
201O
26 
UK   
 
Systematic review & 
Meta synthesis  
 
 
 
AMSTAR score - 8 
 
To determine 
whether specialist 
palliative care teams 
(SPCTs ) improve 
outcomes for patients 
with advanced cancer 
and their caregivers, 
in terms of improving 
symptoms and quality 
of life and/or reducing 
the emotional 
concerns of family 
caregivers.  
 
 
 
Included controlled 
and observational 
studies evaluating 
palliative care. 
Identified 39 studies 
in 40 records.  
 
Patients with 
advanced cancer & 
family carers  
 
Specialist palliative care 
in a community, hospital 
(inpatient/outpatient), 
and /or hospice setting.  
 
Usual care (present 
or historical). Usual 
care comprised 
conventional 
community and 
general 
hospital/oncology 
services. 
 
 
Pain and symptom 
management, quality of 
life and death. Patient 
and carer 
satisfaction/morbidity 
before and after 
bereavement.  
 
 
SPCTs show benefit 
for patients with 
cancer in hospital, 
home or inpatient 
services. Significant 
benefits exist in terms 
of improving pain and 
symptom control, 
satisfaction, anxiety 
and health care 
outcomes (i.e. 
reduced hospital 
admissions and 
length of stays). Some 
studies indicated 
lower costs. 
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Finlay et al 2002
27
   
 
UK  
  
Systematic review 
quantitative and 
qualitative analysis 
 
 
 
 
AMSTAR score ʹ 2 
 
To assess whether 
there was an effect of 
palliative care teams.  
 
 
Included grade I  ? III 
evidence (qualitative 
and quantitative 
reports).  
Identified 43 studies.  
 
 
Not clearly stated, 
although adults 
mentioned in 
included tables. 
 
Palliative care teams / 
subgroups of teams in 
hospital, home and 
hospice (not defined).  
 
 
Usual generalist 
care for 
comparative 
studies. 
Conventional care.  
 
 
15 outcomes in 5 areas: 
1) Patient group  
2) Carer (pre-
bereavement) group -  
3) Carer (post- 
bereavement.) -  
4) Patient/carer group -  
5) Professionals group -  
 
Small positive 
benefits for hospice 
and palliative care 
teams exist. Palliative 
care teams seem 
effective in differing 
settings. 
Multidisciplinary 
teams have 
advantages over uni-
disciplinary 
teams(e.g. reduce 
length of hospital 
stay) Improved pain 
and symptom control, 
satisfaction for carers 
and patients.Home 
care reduced costs. In 
patient hospice 
resulted in greater 
satisfaction 
(especially for carers). 
In patient hospice 
and palliative care 
services either 
improved symptom 
control or had no 
effect and findings 
were equivocal 
regarding QoL.  
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Higginson et al 2003
28
  
 
UK  
 
Meta-analysis, meta-
synthesis and meta-
regression 
 
 
AMSTAR score ʹ 10 
 
To determine the 
effectiveness of 
palliative and hospice 
care teams (PCHCT),  
 
Included evaluative 
controlled, 
comparative and 
observational 
studies. 
Identified 44 studies 
in 69 records.  
 
 
Patients with a 
progressive life 
threatening illness 
and their caregivers 
(defined as family, 
friends, or 
significant others). 
 
Palliative and hospice 
care teams (PCHCT) 
defined  as two or more 
health care workers, at 
least one of whom had 
specialist training or 
worked mainly in 
palliative or hospice 
care. PCHCT were home 
care, hospital-based 
combined home/hospital 
care, inpatient units, and 
integrated teams. 
 
 
 
Usual care was 
routine community 
and general 
hospital/oncology 
services. 
 
Range of patient and 
caregiver outcomes:  
 
A meta-regression of 
26 studies indicated a 
slight positive effect 
on patient outcomes, 
but no effect on 
caregiver outcomes.  
Meta-analysis of 19 
RCTs or quasi-
experimental studies 
demonstrated small 
but significant benefit 
ŽŶƉĂƚŝĞŶƚƐ ?ƉĂŝŶ
other symptoms and 
a non-significant 
trend towards 
benefits for 
satisfaction.  
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Higginson Finlay et al  
2002
29
 Do hospital 
based teams   
UK  
 
meta-analysis, meta-
synthesis  
 
 
AMSTAR score - 11 
 
To determine 
whether hospital-
based palliative care 
teams improve the 
process or outcomes 
of care for patients 
and families at the 
end of life.  
 
 
Included evaluative 
 ? trial design 
comparing  
hospital-based 
palliative care with 
usual care delivery 
(present or 
historical). 
Identified 13 studies.  
 
 
 
 
 
 
Patients 
with a progressive 
life-threatening 
illness, and their 
family, carers, or 
close friends. 
 
Palliative Care Teams 
working in hospitals 
(defined as two or more 
health care workers at 
least one of whom had 
specialist training or 
worked mainly in 
palliative care). 
Interventions were very 
varied. 
 
 
 
Usual care (either 
current  or 
historical)  
 
 
A broad range of 
outcomes and process 
measures related to:  
Patients,  
Carer/family 
member pre/post-
bereavement,  
Population, 
Professionals 
 
 
Hospital-based 
palliative care teams 
offer some benefits 
e.g reduced time in 
hospital and  
improved symptom 
management. 
Satisfaction and 
quality of life 
improved in some 
studies. Some 
benefits exist for 
carers and the 
service.  
 
Thomas et al, 2006
30 
 
Canada 
 
Dedicated community 
teams 
Narrative review  
 
 
AMSTAR score ʹ 6 
 
To identify and 
analyse all published 
RCTs that focus on the 
organization of EOL 
care provided to 
persons who are 
terminally ill, near 
death, or dying.  
 
Included 23 RCTs of 
palliative care  ? 12 
of which focused on 
examined the effect 
of Providing 
Palliative Care 
through Dedicated 
Community Teams.  
 
Terminally ill people 
near death, or 
dying, including  
patients with 
advanced cancer. 
Close family 
members were 
included in 1 study 
 
Dedicated Community 
Teams (described in 
various ways)  
 
Routine or 
standard care usual 
EOL care ; 
customary 
Veterans Affairs 
post discharge  
Care; conventional 
care; standard 
home care or to 
office care 
 
a. ratings of QoL and 
symptom management  
b. satisfaction with care 
c. the duration of the 
palliative period and the 
place of death 
d. costs of palliative are 
compared to usual care 
 
Community or home-
based EOL care 
associated with 
improved QoL and 
symptom 
management.  
There were mixed 
findings about 
patient/carer 
satisfaction Cost data 
were inconclusive  
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ACROSS ALL SETTINGS ʹ COSTS AND COST EFFECTIVENESS  
 
Smith et al  
2014
18
  
Ireland  
 
Narrative review of 
cost and cost 
effectiveness 
 
 
AMSTAR score - 7 
 
Identify studies that 
investigate the cost or 
resource use 
implications or cost-
effectiveness 
ŽĨĂ ‘ƉĂůůŝĂƚŝǀĞĐĂƌĞ
ŝŶƚĞƌǀĞŶƚŝŽŶ ?ƌĞůĂƚŝǀĞ
to 
some type of 
comparator or 
control. 
 
Included any 
comparative study 
design examining 
the cost and/or 
utilisation 
implications of a 
palliative care 
intervention. 
Identified 46 eligible 
studies.   
 
 
Limited information 
was provided about 
study population. 
Where stated, 
cancer & non cancer 
Patients with  
advanced 
illness  
 
A range of hospital-
based, home-based and 
hospice care) models of 
palliative care  
 
 
A range of models 
described in 
various ways as 
usual care; 
conventional care 
or non-PC hospital-
based care.  
 
 
Costs or resource 
use implications and 
cost-effectiveness 
(n=1): point estimates 
that indicate that the 
intervention is cost-
saving 
 
Palliative care is most 
often less costly than 
comparators  
Palliative care has a 
mixed impact on 
resource utilisation  
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Table 3: Quality appraisal* of included reviews  
*Adapted from the AMSTAR tool 
Criteria  7 
 
14 
 
15 
 
16 
 
17 
 
18 
 
19 
 
20 
 
21 
 
22 
 
23 
 
24 
 
25 
 
26 
 
27 
 
28 
 
29 
 
30 
 
1. Was an a priori design provided? CA Y Y Y Y CA CA Y Y Y Y CA CA Y CA Y Y CA 
2. Was there duplicate study 
selection and data extraction? 
N Y N Y Y CA Y CA Y Y CA Y y CA CA Y Y Y 
3. Was a comprehensive  literature 
search performed? 
Y Y Y Y Y Y Y N Y Y Y Y y Y CA Y Y y 
4. Was the status of publication (i.e. 
grey literature) used as an inclusion 
criteria?  
N N Y N CA Y N N CA Y Y CA N CA CA N N Y 
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5. Was a list of studies (included and 
excluded) provided? 
N Y Y Y N Y Y N N N N Y Y Y N Y Y Y 
6. Were the characteristics of the 
included studies provided? 
Y Y Y Y Y Y N Y N Y Y Y Y Y Y Y Y Y 
7. Was the scientific quality of the 
included studies assessed and 
documented? 
Y Y Y Y Y Y N N Y Y N Y Y Y N Y Y Y 
8. Was the scientific quality of the 
included studies used appropriately 
in formulating conclusions? 
Y Y Y Y Y Y N N N Y N Y Y Y Y Y Y N 
9. Were the methods used to 
combine the findings of the studies 
appropriate? 
Y Y Y Y N/A Y N Y Y Y Y Y Y Y CA Y Y Y 
10. Was the likelihood of publication 
bias assessed? 
Y Y Y Y N N N N N N N N Y Y N Y Y N 
11. Was the conflict of interest N Y Y Y N Y Y Y Y Y N Y N N N N Y N 
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stated? 
AMSTAR scores: 
  
7 11 9 11 6 7 5 5 6 8 4 8 9 8 2 10 11 6 
zA䄀 zĞƐ ?EA?EŽ ?A?ĂŶ ?ƚŶƐǁĞƌ ?E ?A?EŽƚĂƉƉůŝĐĂďůĞ 
Quality Scores Yes scores 1  point, except for question 4 where No scores 1 point .  
Quality is described as: High  ? 8-11; Medium  ? 4-7; Low  - 3 or lower 
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